AngioDynamics Appoints Vice President, Regulatory, Quality and Clinical AffairsQUEENSBURY, N.Y.--(BUSINESS WIRE)--
Dec. 9, 2008--
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of
innovative medical devices used by interventional radiologists,
nephrologists and surgeons for the minimally invasive treatment of
cancer and peripheral vascular disease, announced today that it has
appointed
Michael S. Sharp, Ph.D., 59, as the Company's Vice President,
Regulatory, Quality and Clinical Affairs. Dr. Sharp will report to
William Appling, Senior Vice President for
Advanced Research and
Development at
AngioDynamics.
"Michael brings 30 years of experience in regulatory and clinical
affairs working for a variety of medical device companies," said Mr.
Appling. "He is a seasoned executive with a background in successfully
developing clinical affairs and regulatory strategies. We are pleased
that he has agreed to join our team and look forward to his
contributions."
Dr. Sharp was most recently the senior vice president of regulatory,
quality and clinical affairs at ConforMIS, Inc., an image-based
orthopedics company that he joined in 2005. Prior to that he served in
managerial positions in regulatory and clinical affairs for several
medical device companies including Ikonisys, AAI International,
Intelligent Surgical Lasers, VISX, Howmedica, Vision Laboratories, and
Syntex. He was also an assistant professor of oncology and the director
of clinical research and chief regulatory officer for Winship Cancer
Institute at Emory University during 2003 and 2004.
Dr. Sharp is a Fellow of the Regulatory Affairs Professionals Society
and has a wealth of experience in regulatory issues and requirements,
quality initiatives and clinical affairs as they relate to emerging and
more established medical device companies. He has served on the
editorial boards of several professional journals and is the author of
more than 25 papers in the professional literature. Dr. Sharp received
his B.A. from Chapman University, M.A. from the University of North
Dakota and Ph.D. from California Coast University.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices
used by interventional radiologists, surgeons, and other physicians for
the minimally invasive treatment of cancer and peripheral vascular
disease. The Company's diverse product line includes market-leading
radiofrequency ablation and irreversible electroporation resection
systems, vascular access products, angiographic products and
accessories, dialysis products, angioplasty products, drainage products,
thrombolytic products, embolization products and venous products. More
information is available at www.angiodynamics.com.
CONTACT: AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Doug Sherk/Jenifer Kirtland, 415-896-6820
Investor Relations
jkirtland@evcgroup.com
Chris Gale, 646-201-5431
Media
cgale@evcgroup.com
Source: AngioDynamics, Inc.
